Literature DB >> 16717013

Considering the impact of medicine label design characteristics on patient safety.

E Hellier1, J Edworthy, N Derbyshire, A Costello.   

Abstract

Medication errors involving patients receiving the wrong medicines, the wrong dosages or failure to take medicines according to the prescribed schedule are a substantial threat to patient safety. In the medical domain, research evidence on the benefits of improved labelling are piecemeal and often single-product or single-manufacturer driven and often do not inform the more general process of label design. Government and other guidelines on this topic are often low level and non-specific, often failing to give evidence-based guidance. However, there is a wealth of evidence-based research findings in related areas such as food labelling, chemical labelling and more general warnings research, which can provide systematic evidence on the effects of design characteristics such as font size, colour, signal words and linguistic usage on crucial performance variables such as compliance, understandability and discriminability. This research is reviewed and its relevance to medicine labelling is presented.

Entities:  

Mesh:

Year:  2006        PMID: 16717013     DOI: 10.1080/00140130600568980

Source DB:  PubMed          Journal:  Ergonomics        ISSN: 0014-0139            Impact factor:   2.778


  13 in total

1.  Standardised drug labelling in intensive care: results of an international survey among ESICM members.

Authors:  Felix Balzer; Nadine Wickboldt; Claudia Spies; Bernhard Walder; Jérôme Goncerut; Giuseppe Citerio; Andrew Rhodes; Marc Kastrup; Willehad Boemke
Journal:  Intensive Care Med       Date:  2012-04-20       Impact factor: 17.440

2.  Does colour-coded labelling reduce the risk of medication errors?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2009-03

3.  Making electronic prescribing alerts more effective: scenario-based experimental study in junior doctors.

Authors:  Gregory P T Scott; Priya Shah; Jeremy C Wyatt; Boikanyo Makubate; Frank W Cross
Journal:  J Am Med Inform Assoc       Date:  2011-08-11       Impact factor: 4.497

Review 4.  What evidence supports the use of computerized alerts and prompts to improve clinicians' prescribing behavior?

Authors:  Angela Schedlbauer; Vibhore Prasad; Caroline Mulvaney; Shobha Phansalkar; Wendy Stanton; David W Bates; Anthony J Avery
Journal:  J Am Med Inform Assoc       Date:  2009-04-23       Impact factor: 4.497

5.  Exploring the perspectives of potential consumers and healthcare professionals on the readability of a package insert: a case study of an over-the-counter medicine.

Authors:  Carla M Pires; Afonso M Cavaco
Journal:  Eur J Clin Pharmacol       Date:  2014-01-24       Impact factor: 2.953

6.  The legibility of prescription medication labelling in Canada: Moving from pharmacy-centred to patient-centred labels.

Authors:  Susan J Leat; Kristina Ahrens; Abinaya Krishnamoorthy; Deborah Gold; Carlos H Rojas-Fernandez
Journal:  Can Pharm J (Ott)       Date:  2014-05

7.  A comparison of the effects of different typographical methods on the recognizability of printed drug names.

Authors:  Calvin K L Or; Hailiang Wang
Journal:  Drug Saf       Date:  2014-05       Impact factor: 5.606

Review 8.  Computerized prescriber order entry in the outpatient oncology setting: from evidence to meaningful use.

Authors:  V Kukreti; R Cosby; A Cheung; S Lankshear
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

9.  Reading the small print - labelling recommendations for orthopaedic implants.

Authors:  Roger A Haene; Ranbir S Sandhu; Richard Baxandall
Journal:  Ann R Coll Surg Engl       Date:  2009-08-14       Impact factor: 1.891

10.  Assessment of primary labeling of medicines manufactured by Nepalese pharmaceutical industries.

Authors:  Ramesh Sharma Poudel; Shakti Shrestha; Santosh Thapa; Bhupendra Kumar Poudel; Muniraj Chhetri
Journal:  J Pharm Policy Pract       Date:  2018-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.